Basic Information
Basic information for C21orf62-AS1-207-31aa
Peptide Name C21orf62-AS1-207-31aa
Genome Position chr21:32852454-32852490,32862197-32862252[+]
Species Human
Peptide Sequence MSTHLYILPSNNGAVAGESGCYAGTLFFHGV
Peptide Length 31
Unique Yes
Grand Average of Hydropathicity 0.4129
Relative Molecular Mass 3755.14
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000612326;C21orf62-AS1-207
Transcript Length 1568
Coding Ability 0.521
DNA Sequence Corresponding to Peptide ATGTCTACGCATTTATACATCTTGCCCAGTAACAATGGAGCTGTGGCTGGCGAATCTGGATGTTATGCTGGGACATTATTTTTTCACGGGGTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :